Download Citation
Article Source:
In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors
Ahmed M,
Goldgur Y,
Hu J,
Guo HF,
Cheung NKV
(2013)
In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors.
PLOS ONE 8(5): e63359.
https://doi.org/10.1371/journal.pone.0063359